Scientists have shown that a protein found in the blood can be used to precisely monitor disease progression of Alzheimer's long before first clinical signs appear. This blood marker offers new possibilities for testing therapies.
Years before symptoms of Alzheimer's disease manifest, the brain starts changing and neurons are slowly degraded. Scientists at the German Center for Neurodegenerative Diseases (DZNE), the Hertie Institute for Clinical Brain Research (HIH) and the University Hospital Tuebingen now show that a protein found in the blood can be used to precisely monitor disease progression long before first clinical signs appear. This blood marker offers new possibilities for testing therapies. Read more here